Press release
CAR-T Cell Therapy Market Surges to $ 188.84 billion by 2034 With a CAGR of 36.8% 2025-2034
CAR-T Cell Therapy Market
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide CAR-T cell therapy market. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by indication, target antigen, and region in the study, which offers a comprehensive picture of the state of the market.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
CAR-T Cell Therapy (Chimeric Antigen Receptor T-cell Therapy) is an advanced cancer treatment that alters a patient's T-cells to improve their ability to identify and eliminate cancer cells. The procedure entails obtaining T-cells from the patient, altering their genetics to produce a receptor that targets particular cancer antigens, and subsequently reinfusing them back into the patient's body. CAR-T therapy has demonstrated considerable success in treating specific forms of blood cancers, including leukemia and lymphoma.
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐๐ง๐ ๐๐ซ๐๐ง๐๐ฌ:
โ The therapy's capability to induce lasting remission in certain patients with advanced DLBCL has established it as a groundbreaking treatment. The increasing incidence of DLBCL and heightened understanding of advanced immunotherapies have further amplified the demand for CAR-T therapies.
โ Innovations like dual-targeting CARs, armored vehicles, and localized delivery techniques improve the effectiveness and safety profiles of treatments for solid tumors. This expanding body of evidence, along with significant patient demand for innovative treatments, has resulted in heightened investments and research in this field, propelling the advancement of next-generation CAR-T therapies and broadening their use for solid tumors.
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ:
As the market expands, competition is expected to increase with the involvement of numerous businesses. Here are the top companies in the CAR-T cell therapy market:
โข Bluebird Bio
โข Celgene Corporation
โข Gilead Sciences
โข Cellectis
โข Servier Laboratories
โข Pfizer Inc.
โข Merck
โข Amgen
โข Intellia Therapeutics
โข Novartis
โข Caribou Biosciences
๐๐๐-๐ ๐๐๐ฅ๐ฅ ๐๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข In terms of indication, the follicular lymphoma (FL) segment is expected to grow at the fastest pace, with a CAGR of 43.2% during the forecast period due to the rising incidence of refractory and high-risk cancer cases.
โข Based on target antigen, the CD19/CD22 antigen segment, valued at USD 6,258.5 billion in 2024, held the largest market share owing to its established role in treating B-cell malignancies such as diffuse large B-cell lymphoma (DLBCL) and acute lymphoblastic leukemia (ALL).
โข In the global market, the North America CAR-T cell therapy market held a 47.16% market share in 2024 due to the presence of advanced healthcare infrastructure, significant research and development investments, and a high prevalence of hematologic malignancies.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
By Indication Outlook (Revenue, USD Billion, 2020-2034)
โข DLBCL (Diffuse large B-cell lymphoma)
โข ALL (Acute Lymphoblastic Leukemia)
โข CLL (Chronic Lymphocytic Leukemia)
โข MM (Multiple Myeloma)
โข FL (Follicular Lymphoma)
โข Mastozytosis
โข Myeloid Fibrosis
โข MLL (Mixed Lineage Leukemia)
โข Thymic Cancer
โข Glioblastoma
โข AML (Acute Myeloid Leukemia)
โข Other
By Target Antigen Outlook (Revenue, USD Billion, 2020-2034)
โข CD19/CD22
โข BCMA (B-Cell Maturation Antigen)
โข Others
๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐๐ข๐ฌ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ
According to regional analysis, in 2024, North America led the global market, holding about 47% share of the market revenue. The predominance is due to the existence of advanced healthcare facilities, substantial investments in research and development, and a high rate of hematologic cancers.
Also, Europe is anticipated to witness a CAGR of 33.2% during the projection period because of heightened emphasis on broadening access to advanced treatments, along with the growing incidence of relapsed or refractory blood cancers.
โข North America (U.S., Canada)
โข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โข Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
โข Latin America (Brazil, Mexico, Argentina)
โข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Artificial Tendons and Ligaments Market
https://www.polarismarketresearch.com/industry-analysis/artificial-tendons-and-ligaments-market
Targeted Protein Degradation Market
https://www.polarismarketresearch.com/industry-analysis/targeted-protein-degradation-market
Hematology Analyzers and Reagents Market
https://www.polarismarketresearch.com/industry-analysis/hematology-analyzers-and-reagents-market
Liposomal Doxorubicin Market
https://www.polarismarketresearch.com/industry-analysis/liposomal-doxorubicin-market
Arthroscopy Market
https://www.polarismarketresearch.com/industry-analysis/arthroscopy-market
๐๐จ๐ง๐ญ๐๐๐ญ:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
๐๐๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก & ๐๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐๐ง๐:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CAR-T Cell Therapy Market Surges to $ 188.84 billion by 2034 With a CAGR of 36.8% 2025-2034 here
News-ID: 3791022 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Gene Therapy Market Growth Projection: USD 29.01 Billion Valuation by 2035 at 27 โฆ
The quantitative market research report published by Polaris Market Research on Gene Therapy Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Gene Therapy Market size, financial data, and projected future growth. All the information presentedโฆ
Europe Armor Materials Market to Reach USD 6.09 Billion by 2034, Growing at 7.0% โฆ
Market Size and Share:
Europe Armor Materials Market is currently valued at USD 3.10 billion in 2024 and is anticipated to generate an estimated revenue of USD 6.09 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034
Polaris Market Research has introduced the latest market researchโฆ
Europe Antibody Specificity Testing Market Projected to Hit USD 433.81 Million b โฆ
The quantitative market research report published by Polaris Market Research on Europe Antibody Specificity Testing Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Europe Antibody Specificity Testing Market size, financial data, and projected future growth.โฆ
U.S. Extended Detection and Response (XDR) Market to Reach USD 24.86 Billion by โฆ
The quantitative market research report published by Polaris Market Research on U.S. Extended Detection and Response (XDR) Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, U.S. Extended Detection and Response (XDR) Market size, financial data,โฆ
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R โฆ
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copyโฆ
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re โฆ
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnologicalโฆ
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod โฆ
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Currentโฆ
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp โฆ
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,โฆ
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect โฆ
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, typeโฆ
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends โฆ
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimerโs and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emergingโฆ
